]>

The Annual General Meeting : 2003


CeNeS Pharmaceuticals plc ("CeNeS" or "the Company")(LSE:CEN), London
UK, 12th August 2003: At the AGM held yesterday all resolutions
proposed at the meeting were duly passed.

The CeNeS Chairman, Alan Goodman commented, "The CeNeS Board is very
pleased with the progress the Company has made in the last few
months. As announced on 8th August, CeNeS has completely removed
Elan's interest in the shares of CeNeS and welcomes the new
institutional investors that took over Elan's interests. The
Company's strong cash position and late stage clinical pipeline
focused on the treatment of pain means that CeNeS is now well placed
to move forward and deliver increased value to shareholders".

For more information please contact:

CeNeS Pharmaceuticals plc
Alan Goodman
Neil Clark
Tel: +44 (0)1223 266466
Fax: +44 (0)1223 266467

Euro RSCG Life NRP
Dr Douglas Pretsell
Tel: +44 (0)20 7726 4452
Fax: +44 (0)20 7726 4453



- ---END OF MESSAGE---
Copyright � Hugin ASA 2003. All rights reserved.-----BEGIN PGP SIGNATURE-----
Version: PGP 6.5.8

iQA/AwUBPziCcu6RaHz0nSHVEQJ0/gCgkYSKz9773/Q9XXb8V2PnBOIKb0QAoIqM
nI41JaZawyDNJNBXz5R5zzYB
=dwNJ
-----END PGP SIGNATURE-----